Perry Cross recently caught up with Professor James St John at Griffith University’s Clem Jones Centre for Neurobiology and Stem Cell Research for an important update on Griffith University’s Human Clinical Trial.

This world-first Phase I study will combine transplantation of participants’ own specialised olfactory cells – formed into cellular nerve bridges – with intensive rehabilitation for chronic spinal cord injury.

We understand and share the community’s frustration with the delays, particularly after such a long and hopeful wait for the trial to begin.
In this video, James shares the trial’s current progress, explains the delays the team has been working through and outlines the next steps.